MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition

Amaral, Teresa; Sinnberg, Tobias; Meier, Friedegund; Krepler, Clemens; Levesque, Mitchell; Niessner, Heike; Garbe, Claus

dc.contributor.author	Amaral, Teresa
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Niessner, Heike
dc.contributor.author	Garbe, Claus
dc.date.accessioned	2018-02-16T08:45:34Z
dc.date.available	2018-02-16T08:45:34Z
dc.date.issued	2017
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/80561
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2016.12.012	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01632
utue.publikation.seiten	93-101	de_DE
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Meier, Friedegund
utue.personen.roh	Krepler, Clemens
utue.personen.roh	Levesque, Mitchell
utue.personen.roh	Niessner, Heike
utue.personen.roh	Garbe, Claus
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	73	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE